Clinical Trial Update: Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed with cisplatin and radiotherapy for unresectable locally advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED